MedTrace Logo

Hypothalamic-pituitary Effects After Endoscopic Third Ventriculostomy

NCT01675037 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2017-03-14

No results posted yet for this study

Summary

Background: Endoscopic third ventriculostomy (ETV) is a standard procedure for the treatment of obstructive hydrocephalus in children and adults. Perforation of the third ventricle floor which is part of the hypothalamic-pituitary neuronal network is the key of this surgical procedure.

Purpose: There are no prospective data available about the endocrine effects after ETV in children and adults. The principal aim of this prospective study is to evaluate the variability of hypothalamic-pituitary hormones and clinical effects in children and adults after ETV in order to plan a multicentric study.

Conditions

  • Obstructive Hydrocephalus

Interventions

OTHER

Biological evaluation

Complete hypothalamic-pituitary hormonal evaluation

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Franck-Emmanuel Roux, MD,PHD · University Hospital, Toulouse

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01675037 on ClinicalTrials.gov